V Biton

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi request reprint Clinical pharmacology and mechanism of action of zonisamide
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, AR, USA
    Clin Neuropharmacol 30:230-40. 2007
  2. ncbi request reprint Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy
    Victor Biton
    Arkansas Epilepsy Program, 2 Lile Court, Suite 100, Little Rock, AR 72205, USA
    CNS Drugs 17:781-91. 2003
  3. ncbi request reprint Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, AR, USA
    Expert Opin Drug Metab Toxicol 2:1009-18. 2006
  4. ncbi request reprint Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, Arkansas 72205, USA
    Neurologist 12:163-7. 2006
  5. ncbi request reprint Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures
    V Biton
    Arkansas Epilepsy Program, Little Rock, AR 72205, USA
    Neurology 65:1737-43. 2005
  6. ncbi request reprint Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Neurology 56:172-7. 2001
  7. ncbi request reprint A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Neurology 52:1330-7. 1999
  8. ncbi request reprint Topiramate titration and tolerability
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Ann Pharmacother 35:173-9. 2001
  9. ncbi request reprint Zonisamide: newer antiepileptic agent with multiple mechanisms of action
    Victor Biton
    Two Lile Court, Suite 100, Little Rock, AR 72205, USA
    Expert Rev Neurother 4:935-43. 2004
  10. ncbi request reprint Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial
    Victor Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    J Child Neurol 18:133-9. 2003

Detail Information

Publications17

  1. ncbi request reprint Clinical pharmacology and mechanism of action of zonisamide
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, AR, USA
    Clin Neuropharmacol 30:230-40. 2007
    ....
  2. ncbi request reprint Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy
    Victor Biton
    Arkansas Epilepsy Program, 2 Lile Court, Suite 100, Little Rock, AR 72205, USA
    CNS Drugs 17:781-91. 2003
    ..The most appropriate therapeutic choice is a weight-neutral medication unless circumstances dictate otherwise...
  3. ncbi request reprint Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, AR, USA
    Expert Opin Drug Metab Toxicol 2:1009-18. 2006
    ..The pharmacokinetic, toxicology and safety profiles of lamotrigine make the drug suitable for use across a spectrum of patients with epilepsy...
  4. ncbi request reprint Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, Arkansas 72205, USA
    Neurologist 12:163-7. 2006
    ..Weight change, either gain or loss, is a common AED side effect, conferring multiple risks of additional morbidity...
  5. ncbi request reprint Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures
    V Biton
    Arkansas Epilepsy Program, Little Rock, AR 72205, USA
    Neurology 65:1737-43. 2005
    ..To evaluate the efficacy and tolerability of adjunctive lamotrigine in primary generalized tonic-clonic (PGTC) seizures in a randomized, double-blind, placebo-controlled trial...
  6. ncbi request reprint Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Neurology 56:172-7. 2001
    ..Weight gain associated with valproate was significant within 10 weeks after initiating therapy and continued throughout the study. Efficacy of lamotrigine was comparable with that of valproate; lamotrigine tended to be better tolerated...
  7. ncbi request reprint A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Neurology 52:1330-7. 1999
    ..The efficacy and safety of topiramate as adjunctive therapy for the treatment of primary generalized tonic-clonic (PGTC) seizures were investigated in a randomized, double-blind, placebo-controlled study...
  8. ncbi request reprint Topiramate titration and tolerability
    V Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Ann Pharmacother 35:173-9. 2001
    ..To evaluate the tolerability and efficacy of two titration rates for topiramate initiated as adjunctive therapy in adults with partial-onset seizures, with or without secondary generalization, in a multicenter, double-blindtrial...
  9. ncbi request reprint Zonisamide: newer antiepileptic agent with multiple mechanisms of action
    Victor Biton
    Two Lile Court, Suite 100, Little Rock, AR 72205, USA
    Expert Rev Neurother 4:935-43. 2004
    ..A review of the chemical properties, pharmacokinetics, metabolism, potential mechanisms of action, efficacy in seizure and nonseizure disorders, and tolerability was therefore thought to be timely...
  10. ncbi request reprint Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial
    Victor Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    J Child Neurol 18:133-9. 2003
    ..Whereas weight remained stable in adolescents treated with lamotrigine, weight increased in those treated with valproate by week 10 of this study and continued to increase at the end of the study...
  11. ncbi request reprint Topiramate in patients with juvenile myoclonic epilepsy
    Victor Biton
    Arkansas Epilepsy Program, Little Rock 72205, USA
    Arch Neurol 62:1705-8. 2005
    ..Juvenile myoclonic epilepsy is one of the most common idiopathic generalized epilepsies, with most patients experiencing PGTCS...
  12. ncbi request reprint Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures
    Victor Biton
    Arkansas Epilepsy Program, Little Rock, Arkansas 77025, USA
    Epilepsia 49:418-24. 2008
    ..This multicenter, double-blind, double-dummy, randomized, inpatient trial evaluated the safety, tolerability, and pharmacokinetics of intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures...
  13. ncbi request reprint A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy
    Mark E Sale
    Pharmacokinetic Modeling and Simulation, GlaxoSmithKline, Research Triangle Park, NC, USA
    Epilepsy Behav 6:63-70. 2005
    ....
  14. ncbi request reprint Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials
    Ilo E Leppik
    MINCEP Epilepsy Care and University of Minnesota, 5775 Wayzata Boulevard, Suite 255, Minneapolis, MN 55416, USA
    Epilepsia 44:1585-7. 2003
    ..To determine the effect of levetiracetam (LEV) on partial seizure subtypes (simple partial, complex partial, and secondarily generalized seizures) in patients with refractory epilepsy...
  15. ncbi request reprint Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures
    Elinor Ben-Menachem
    Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    Epilepsia 48:1308-17. 2007
    ....
  16. ncbi request reprint Divalproex-ER pharmacokinetics in older children and adolescents
    Sandeep Dutta
    Abbott Laboratories, Abbott Park, Illinois, USA
    Pediatr Neurol 30:330-7. 2004
    ....
  17. ncbi request reprint Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study
    Richard L Rauck
    The Center for Clinical Research, Winston Salem, NC, USA
    Clin J Pain 23:150-8. 2007
    ..Peripheral diabetic neuropathy affects between 20% and 45% of patients with diabetes...